Did not become law. It stopped in the General Assembly on June 30, 2023. The 2022–2023 session has ended.
2022–2023 Session
Assembly Bill 2839
Requires health insurance carriers to provide coverage for epinephrine auto-injector devices and asthma inhalers; limits cost sharing for health insurance coverage of insulin.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the General Assembly
Sponsor from Feb 14
Robert J. Karabinchak, Annette Quijano
Chief co-sponsors from Feb 14
Chief co-sponsor from Mar 24
Its course
February 28, 2022 to June 30, 2023, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action7 actions on 6 days
In the General AssemblyFeb 28 to Jun 30 · stopped487 days
Financial Institutions and InsuranceFeb 28 to Mar 1414 days
HealthMar 14 to May 2673 days
AppropriationsMay 26 to Jun 22392 days
BudgetJun 27 to Jun 270 days
Amendments
Each amendment offered, and what became of it.
General Assembly committee amendmentAdopted
Adopted May 26
General Assembly committee amendmentAdopted
Adopted Jun 27, 2023
Text
Each version as the Legislature printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislature published it is below.
In the General Assembly Feb 28 – Jun 30, 2023
- Feb 28Introduced in the General Assembly and sent to Financial Institutions and Insurance
- Mar 14Financial Institutions and Insurance recommended it
- Sent to Health
- May 26Health recommended it as amended
- Sent to Appropriations
- Jun 22, 2023Appropriations recommended it
- Read a second time
- Jun 27, 2023Sent to Budget
- Budget recommended it as amended
- Read a second time
- Jun 30, 2023Carried on in S1614